<article title='Catatonia'><paragraph><template><target>About</target><arg>the catatonic state</arg></template><template><target>distinguish</target><arg>Katatonia</arg><arg>cataplexy</arg><arg>catalepsy</arg><arg>Catalonia</arg><arg>Cat Tonic</arg><arg>Catatactatagc</arg></template></paragraph><paragraph><template><target>Infobox disease</target><arg name="Name"><space/>Catatonia
</arg><arg name="Field"><space/>[[Neurology]], [[psychiatry]]
</arg><arg name="ICD10"><space/>{{ICD10|F|06|1|f|06}}
</arg><arg name="ICD9"><space/>{{ICD9|293.89}}
</arg><arg name="MeshID"><space/>D002389
</arg></template></paragraph><paragraph><bold>Catatonia</bold><space/>is a state of neurogenic motor immobility and behavioral abnormality manifested by<space/><link><target>stupor</target></link>. It was first described in 1874 by<space/><link><target>Karl Ludwig Kahlbaum</target></link>, in<space/><italics>Die Katatonie oder das Spannungsirresein</italics><extension extension_name='ref'>http://web.archive.org/web/20080209213229/http://www.entwicklung-der-psychiatrie.de/seiten/24.1_kahlbaum_die_katatonie.htm, Archived copy (Internet Archive)</extension><space/>(<italics>Catatonia or Tension Insanity</italics>).</paragraph><paragraph>In the<space/><italics><link><target>Diagnostic and Statistical Manual of Mental Disorders</target></link></italics><space/>5th edition catatonia is not recognized as a separate disorder, but is associated with psychiatric conditions such as<space/><link><target>schizophrenia</target></link><space/>(catatonic type),<space/><link><target>bipolar disorder</target></link>,<space/><link><target>post-traumatic stress disorder</target></link>,<space/><link><target>Clinical depression</target><part>depression</part></link><space/>and other mental disorders,<space/><link><target>narcolepsy</target></link>, as well as<space/><link><target>drug abuse</target></link><space/>or<space/><link><target>overdose</target></link><space/>(or both). It may also be seen in many medical disorders including infections (such as<space/><link><target>encephalitis</target></link>),<space/><link><target>autoimmune disorder</target><trail>s</trail></link>, focal neurologic lesions (including<space/><link><target>stroke</target><trail>s</trail></link>), metabolic disturbances, alcohol withdrawal<extension extension_name='ref' name="Geoffroy-2012"><template><target>Cite journal</target><arg name="author"><space/>Geoffroy PA, Rolland B, Cottencin O.<space/></arg><arg name="title"><space/>Catatonia and alcohol withdrawal: a complex and underestimated syndrome.<space/></arg><arg name="journal"><space/>Alcohol Alcohol.<space/></arg><arg name="volume"><space/>47<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>288–90<space/></arg><arg name="date">May–June 2012<space/></arg><arg name="doi"><space/>10.1093/alcalc/agr170<space/></arg><arg name="pmid"><space/>22278315<space/></arg></template></extension><space/>and abrupt or overly rapid<space/><link><target>benzodiazepine withdrawal syndrome</target><part>benzodiazepine withdrawal</part></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Rosebush PI<space/></arg><arg name="author2">Mazurek MF.<space/></arg><arg name="date">August 1996<space/></arg><arg name="title"><space/>Catatonia after benzodiazepine withdrawal<space/></arg><arg name="journal"><space/>Journal of clinical psychopharmacology.<space/></arg><arg name="volume"><space/>16<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>315–9<space/></arg><arg name="pmid"><space/>8835707<space/></arg><arg name="doi"><space/>10.1097/00004714-199608000-00007<space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author">Deuschle M, Lederbogen F<space/></arg><arg name="title">Benzodiazepine withdrawal-induced catatonia<space/></arg><arg name="journal">Pharmacopsychiatry<space/></arg><arg name="volume">34<space/></arg><arg name="issue">1<space/></arg><arg name="pages">41–2<space/></arg><arg name="date">January 2001<space/></arg><arg name="pmid">11229621<space/></arg><arg name="doi"><space/>10.1055/s-2001-15188</arg><arg name="url"></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author">Kanemoto K, Miyamoto T, Abe R<space/></arg><arg name="title">Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal<space/></arg><arg name="journal">Seizure<space/></arg><arg name="volume">8<space/></arg><arg name="issue">6<space/></arg><arg name="pages">364–6<space/></arg><arg name="date">September 1999<space/></arg><arg name="pmid">10512781<space/></arg><arg name="doi">10.1053/seiz.1999.0309<space/></arg><arg name="url">http://linkinghub.elsevier.com/retrieve/pii/S1059-1311(99)90309-6</arg></template></extension></paragraph><paragraph>It can be an adverse reaction to prescribed medication. It bears similarity to conditions such as<space/><link><target>encephalitis lethargica</target></link><space/>and<space/><link><target>neuroleptic malignant syndrome</target></link>. There are a variety of treatments available;<space/><link><target>benzodiazepine</target><trail>s</trail></link><space/>are a first-line treatment strategy.<space/><link><target>Electro-convulsive therapy</target></link><space/>is also sometimes used. There is growing evidence for the effectiveness of<space/><link><target>NMDA antagonists</target></link><space/>for benzodiazepine resistant catatonia.<extension extension_name='ref' name="Daniels-2009"><template><target>Cite journal</target><arg name="last1"><space/>Daniels<space/></arg><arg name="first1"><space/>J.<space/></arg><arg name="title"><space/>Catatonia: clinical aspects and neurobiological correlates.<space/></arg><arg name="journal"><space/>J Neuropsychiatry Clin Neurosci<space/></arg><arg name="volume"><space/>21<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>371–80<space/></arg><arg name="year"><space/>2009<space/></arg><arg name="doi"><space/>10.1176/appi.neuropsych.21.4.371<space/></arg><arg name="pmid"><space/>19996245<space/></arg></template></extension><space/>Antipsychotics are sometimes employed but require caution as they can worsen symptoms and have serious adverse effects.<extension extension_name='ref' name="Fink &amp; Taylor"></extension></paragraph><heading level='2'>Features</heading><paragraph>Patients with catatonia may experience an extreme loss of motor skill or even constant hyperactive motor activity. Catatonic patients will sometimes hold rigid poses for hours and will ignore any external stimuli. Patients with catatonic excitement can suffer from exhaustion if not treated. Patients may also show stereotyped, repetitive movements.</paragraph><paragraph>They may show specific types of movement such as<space/><link><target>waxy flexibility</target></link>, in which they maintain positions after being placed in them through someone else in which they resist movement in proportion to the force applied by the examiner. They may repeat meaningless phrases or speak only to repeat what the examiner says.</paragraph><paragraph>While catatonia is only identified as a symptom of<space/><link><target>schizophrenia</target></link><space/>in present psychiatric classifications, it is increasingly recognized as a syndrome with many faces. It appears as the Kahlbaum syndrome (motionless catatonia), malignant catatonia (neuroleptic malignant syndrome,<space/><link><target>Serotonin syndrome</target><part>toxic serotonin syndrome</part></link>), and excited forms (delirious mania, catatonic excitement,<space/><link><target>oneirophrenia</target></link>).<extension extension_name='ref' name="Fink &amp; Taylor">Fink M, Taylor MA: CATATONIA: A Clinician's Guide to Diagnosis and Treatment, Cambridge U Press, 2003&quot;</extension><space/>It has also been recognized as grafted on to<space/><link><target>autism spectrum disorders</target></link>.<extension extension_name='ref'>Dhossche D et al.: Catatonia in Autism Spectrum Disorders, Elsevier, Amsterdam, 2006</extension></paragraph><heading level='2'>Diagnostic criteria</heading><paragraph>According to the<space/><link><target>DSM-V</target></link>, &quot;Catatonia Associated with Another Mental Disorder (Catatonia Specifier)&quot; is diagnosed if the clinical picture is dominated by at least three of the following:<extension extension_name='ref' name="DSM-5-introduction"><template><target>Cite book</target><arg name="first">
</arg><arg name="last"><space/>American Psychiatric Association
</arg><arg name="year"><space/>2013
</arg><arg name="title">Diagnostic and Statistical Manual of Mental Disorders
</arg><arg name="edition">Fifth
</arg><arg name="publisher">American Psychiatric Publishing
</arg><arg name="location">Arlington, VA
</arg><arg name="pages">119
</arg><arg name="isbn"><space/>978-0-89042-555-8
</arg></template></extension></paragraph><list type='bullet'><listitem><link><target>stupor</target></link><space/>(i.e., no psychomotor activity; not actively relating to environment)</listitem><listitem><link><target>catalepsy</target></link><space/>(i.e., passive induction of a posture held against gravity)</listitem><listitem><link><target>waxy flexibility</target></link><space/>(i.e., allow positioning by examiner and maintain position)</listitem><listitem><link><target>mutism</target></link><space/>(i.e., no, or very little, verbal response [exclude if known aphasia])</listitem><listitem>negativism (i.e., opposition or no response to instructions or external stimuli)</listitem><listitem>posturing (i.e., spontaneous and active maintenance of a posture against gravity)</listitem><listitem>mannerism (i.e., odd, circumstantial caricature of normal actions)</listitem><listitem><link><target>stereotypy</target></link><space/>(i.e., repetitive, abnormally frequent, non-goal-directed movements)</listitem><listitem>agitation, not influenced by external stimuli</listitem><listitem>grimacing</listitem><listitem><link><target>echolalia</target></link><space/>(i.e., mimicking another's speech)</listitem><listitem><link><target>echopraxia</target></link><space/>(i.e., mimicking another's movements)</listitem></list><heading level='3'>Subtypes</heading><list type='bullet'><listitem><bold><link><target>Stupor</target></link></bold><space/>is a motionless,<space/><link><target>apathy</target><part>apathetic</part></link><space/>state in which one is oblivious or does not react to external<space/><link><target>stimulus (physiology)</target><part>stimuli</part></link>.<space/><link><target>motor skill</target><part>Motor activity</part></link><space/>is nearly non-existent. Individuals in this state make little or no eye contact with others and may be mute and rigid. One might remain in one position for a long period of time, and then go directly to another position immediately after the first position.</listitem></list><list type='bullet'><listitem><bold>Catatonic excitement</bold><space/>is a state of constant purposeless<space/><link><target>Psychomotor agitation</target><part>agitation</part></link><space/>and excitation. Individuals in this state are extremely hyperactive, although, as aforementioned, the activity seems to lack purpose. The individual may also experience delusions or hallucinations.<extension extension_name='ref'>Nolen-Hoeksema. Abnormal psychology. (6th ed., p. 224)</extension><space/>It is commonly cited as one of the most dangerous mental states in psychiatry.<extension extension_name='ref'><template><target>cite book</target><arg name="last">Maric<space/></arg><arg name="first">J.</arg><arg name="title">Clinical Psychiatry<space/></arg><arg name="publisher">Nolit, Belgrade</arg><arg name="year">2000</arg></template></extension></listitem></list><list type='bullet'><listitem><bold>Malignant catatonia</bold><space/>is an acute onset of excitement, fever, autonomic instability, delirium and may be fatal.<extension extension_name='ref'>Semple,David.&quot;oxford hand book of psychiatry&quot; Oxford press. 2005.</extension></listitem></list><heading level='3'>Rating scale</heading><paragraph>Fink and Taylor developed a catatonia rating scale to identify the syndrome.<extension extension_name='ref' name="Fink &amp; Taylor"></extension><space/>A diagnosis is verified by a<space/><link><target>benzodiazepine</target></link><space/>or<space/><link><target>barbiturate</target></link><space/>test. The diagnosis is validated by the quick response to either benzodiazepines or<space/><link><target>electroconvulsive therapy</target></link><space/>(ECT). While proven useful in the past, barbiturates are no longer commonly used in<space/><link><target>psychiatry</target></link>; thus the option of either benzodiazepines or ECT.</paragraph><heading level='2'>Treatment</heading><paragraph>Initial treatment is aimed at providing symptomatic relief.<space/><link><target>Benzodiazepine</target><trail>s</trail></link><space/>are the first line of treatment, and high doses are often required. A test dose of 12&amp;nbsp;mg of intramuscular<space/><link><target>lorazepam</target></link><space/>will often result in marked improvement within half an hour. In France,<space/><link><target>zolpidem</target></link><space/>has also been used in diagnosis, and response may occur within the same time period. Ultimately the underlying cause needs to be treated.<extension extension_name='ref' name="Fink &amp; Taylor"></extension></paragraph><paragraph><link><target>Electroconvulsive therapy</target></link><space/>(ECT) is an effective treatment for catatonia.<space/><link><target>Antipsychotic</target><trail>s</trail></link><space/>should be used with care as they can worsen catatonia and are the cause of<space/><link><target>neuroleptic malignant syndrome</target></link>, a dangerous condition that can mimic catatonia and requires immediate discontinuation of the antipsychotic.<extension extension_name='ref' name="Fink &amp; Taylor"></extension></paragraph><paragraph>Excessive<space/><link><target>glutamate</target></link><space/>activity is believed to be involved in catatonia; when first-line treatment options fail,<space/><link><target>NMDA antagonists</target></link><space/>such as<space/><link><target>amantadine</target></link><space/>or<space/><link><target>memantine</target></link><space/>are used. Amantadine may have an increased incidence of tolerance with prolonged use and can cause psychosis, due to its additional effects on the dopamine system. Memantine has a more targeted pharmacological profile for the glutamate system, reduced incidence of psychosis and may therefore be preferred for individuals who cannot tolerate amantadine.<space/><link><target>Topiramate</target></link>, is another treatment option for resistant catatonia; it produces its therapeutic effects by producing glutamate antagonism via modulation of AMPA receptors.<extension extension_name='ref' name="Carroll-2007"><template><target>Cite journal</target><arg name="last1"><space/>Carroll<space/></arg><arg name="first1"><space/>BT.<space/></arg><arg name="last2"><space/>Goforth<space/></arg><arg name="first2"><space/>HW.<space/></arg><arg name="last3"><space/>Thomas<space/></arg><arg name="first3"><space/>C.<space/></arg><arg name="last4"><space/>Ahuja<space/></arg><arg name="first4"><space/>N.<space/></arg><arg name="last5"><space/>McDaniel<space/></arg><arg name="first5"><space/>WW.<space/></arg><arg name="last6"><space/>Kraus<space/></arg><arg name="first6"><space/>MF.<space/></arg><arg name="last7"><space/>Spiegel<space/></arg><arg name="first7"><space/>DR.<space/></arg><arg name="last8"><space/>Franco<space/></arg><arg name="first8"><space/>KN.<space/></arg><arg name="last9"><space/>Pozuelo<space/></arg><arg name="first9"><space/>L.<space/></arg><arg name="last10"><space/>Munoz<space/></arg><arg name="first10"><space/>C.<space/></arg><arg name="title"><space/>Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes<space/></arg><arg name="url"><space/>http://neuro.psychiatryonline.org/cgi/reprint/19/4/406<space/></arg><arg name="journal"><space/>J Neuropsychiatry Clin Neurosci<space/></arg><arg name="volume"><space/>19<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>406–12<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="doi"><space/>10.1176/appi.neuropsych.19.4.406<space/></arg><arg name="pmid"><space/>18070843<space/></arg><arg name="display-authors"><space/>8<space/></arg></template></extension></paragraph><heading level='2'>See also</heading><list type='bullet'><listitem><link><target>Blank expression</target></link></listitem><listitem><italics><link><target>Awakenings</target></link></italics><space/>- 1990 film with Catatonia as a plot topic</listitem><listitem><link><target>Botulism</target></link></listitem><listitem><link><target>Disorganized schizophrenia</target></link></listitem><listitem><link><target>Karolina Olsson</target></link></listitem><listitem><link><target>Oneiroid syndrome</target></link></listitem><listitem><link><target>Paranoid schizophrenia</target></link></listitem><listitem><link><target>Persistent vegetative state</target></link></listitem><listitem><link><target>Apparent death#Tonic immobility</target><part>Tonic immobility</part></link></listitem></list><heading level='2'>References</heading><paragraph><template><target>reflist</target><arg>2</arg></template></paragraph><heading level='2'>External links</heading><list type='bullet'><listitem><link type='external' href='http://www.minddisorders.com/Br-Del/Catatonic-disorders.html'>Encyclopedia of Mental Disorders - Catatonic Disorders</link></listitem></list><paragraph><template><target>Mental and behavioral disorders</target><arg name="selected"><space/>symptoms</arg></template></paragraph><paragraph><link><target>Category:Mental and behavioural disorders</target></link><link><target>Category:Schizophrenia</target></link></paragraph></article>